UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~March 3031, ~~2020~~2021

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from___________to___________

Commission File Number: 000-55505

BRIDGEWAY NATIONAL CORP.

(Exact Name of Registrant as Specified in its Charter)

Delaware		45-5523835
(State or Other Jurisdiction of		(I.R.S. Employer
Incorporation or Organization)		Identification No.)

1015 15^th Street NW, Suite 1030, Washington, DC		20005
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number including area code: 1-202-846-7869

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act (Check one):

Large accelerated filer [ ]	Accelerated filer [ ]

Non-accelerated filer [ ]	Smaller reporting company [X]

Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A Common Stock		BDGY		OTC Pink

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

Class		Outstanding as of ~~November~~June 1614, ~~2020~~2021
Class A Common Stock, $0.001 par value		92,~~640~~410,~~915~~229

BRIDGEWAY NATIONAL CORP.

TABLE OF CONTENTS

	~~Page~~	Page
PART I - FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements (Unaudited)
Consolidated Balance Sheets as of September 30, 2020 (Unaudited) and December 31, 2019	F-1
Consolidated Balance Sheets as of March 31, 2021 (Unaudited) and December 31, 2020		F-1
Consolidated Statements of Operations for the three- and nine-months period ended September 30, 2020 and September 30, 2019 (Unaudited)	F-2
Consolidated Statements of Operations for the three months period ended March 31, 2021 and March 31, 2020 (Unaudited)		F-2
Consolidated Statements of Changes in Stockholders’ Deficiency for the three- and nine-months period ended September 30, 2020 and September 30, 2019 (Unaudited)	F-3
Consolidated Statements of Changes in Stockholders’ Deficiency for the three months period ended March 31, 2021 and March 31, 2020 (Unaudited)		F-3
Consolidated Statements of Cash Flows for the nine months period ended September 30, 2020 and September 30, 2019 (Unaudited)	F-4
Consolidated Statements of Cash Flows for the three months period ended March 31,2021 and March 31,2020 (Unaudited)		F-4
Notes to the Consolidated Financial Statements (Unaudited)	~~F-5~~	F-5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	3	3
Item 3. Quantitative and Qualitative Disclosures About Market Risk	7	6
Item 4. Controls and Procedures	7	6
PART II - OTHER INFORMATION	8	7
Item 1. Legal Proceedings	8	7
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	8	7
Item 3. Defaults Upon Senior Securities	8	7
Item 4. Mine Safety Disclosure	8	8
Item 5. Other Information	8	8
Item 6. Exhibits	8	8
SIGNATURES	9	9

-2-

BRIDGEWAY NATIONAL CORP.

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

	As at
	September 30, 2020			December 31, 2019
	March 31, 2021			December 31, 2020
ASSETS
Current Assets:
Cash	$	~~147~~90,~~316~~183		$	-1,915
Deferred financing fees		400,000			-
Total Current Assets		90,183			1,915
Due from related parties		-			84,997
Property and equipment, net		76,936			79,273
Total Current Assets		547,316			84,997
Rights-of-use assets		682,702			722,088
Property and equipment, net		81,690			3,983
Total Assets	$	849,821		$	803,276
Rights-of-use assets		761,475			-
Total Assets	$	1,390,481		$	88,980
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Current Liabilities:
Accounts payable		~~149~~217,~~884~~098			87217,~~746~~098
Accrued interest expenses on convertible notes payable		58,895			-
Accrued expenses		541,250			417,960
Dividend payable		41,277			11,318
Accrued interest expenses on convertible notes payable		156,880			94,727
Convertible notes payable, net of unamortized discount $376,778 (2019 - $nil)		623,222			-
Dividend payable		64,352			54,366
Derivative liability – notes and warrants		2,292,304			-
Due to related party		69,903			81,277
Right of use liabilities – operating leases, current		120,590			-
Convertible notes payable, net of unamortized discount $96,166 (2020 - $184,388)		1,222,834			1,086,612
Total Current Liabilities		3,286,172			99,064
Derivative liability – notes and warrants		1,588,272			1,717,337
Right of use liabilities – operating leases, long term		680,271			-
Right of use liabilities – operating leases, current		130,644			115,547
Total Liabilities		3,966,443			99,064
Total Current Liabilities		3,991,233			3,784,924
Long-term Notes payable		150,000			-
Right of use liabilities – operating leases, long term		612,362			657,457
Total Liabilities		4,753,595			4,442,381
Stockholders’ Deficiency:
Series A preferred stock, $0.001 par value, 62,374,819 shares authorized, 1,000 shares issued and outstanding (December 31, 2019 – 1,000), respectively		1			1
Series A preferred stock, $0.001 par value, 62,374,819 shares authorized, 1,000 shares issued and outstanding (December 31, 2020 – 1,000), respectively		1			1
Series B preferred stock, $0.001 par value, 125,181 shares authorized, 125,001 shares issued and outstanding (December 31, 2019 – 96,429 shares issued and outstanding), respectively		125			96
Series B preferred stock, $0.001 par value, 125,181 shares authorized, 125,001 shares issued and outstanding (December 31, 2020 – 125,001 shares issued and outstanding), respectively		125			125
Class B common stock, $0.001 par value, 18,750,000 shares authorized, nil shares issued and outstanding		-			-
Class A common stock, $0.001 par value, 168,750,000 shares authorized, 9,640,915 and 9,640,915 issued and outstanding (December 31, 2019 – 9,640,915 and 9,640,915 issued and outstanding), respectively		9,642			9,642
Class A common stock, $0.001 par value, 168,750,000 shares authorized, 2,410,229 and 2,410,229 issued and outstanding (December 31, 2020 – 2,410,229 and 2,410,229 issued and outstanding), respectively		2,410			2,410
Additional paid-in capital		7,~~201~~378,~~080~~923			67,~~885~~388,~~944~~909
Accumulated deficit		(911,~~786~~285,~~810~~233	)		(611,~~905~~030,~~767~~550	)
Total Stockholders’ deficiency		(23,~~575~~903,~~962~~774	)		(103,~~084~~639,105	)
Total Liabilities and Stockholders’ Deficiency	$	1849,~~390,481~~821		$	88803,~~980~~276

See accompanying notes to the unaudited consolidated financial statements.

F-1

BRIDGEWAY NATIONAL CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

	For the three months ended						~~For the nine months ended~~
	September 30,			September 30,			September 30,			September 30,
	March 31,			March 31,
	2020			2019			2020			2019
	2021			2020
Operating expenses:
Professional fees		210,~~497~~670			1432,~~127~~210			~~60,232~~			~~105,284~~
General and administrative		~~158~~160,~~444~~099			~~567~~176,422			~~630,441~~			~~149,875~~
Amortization expense		241,~~610~~723			781,958			~~7,199~~			~~234~~
Total operating expenses		~~163~~212,~~551~~492			14210,~~772~~590			~~697,872~~			~~255,393~~
Loss from operations		(~~163~~212,~~551~~492	)		(14210,~~772~~590	)		~~(697,872~~	)		~~(255,393~~	)
Other income (expenses)
Change in fair value of derivative liabilities		~~(586~~129,~~322~~065	)		-37,994			~~146,694~~			-
Loss on derivative liabilities		-			-(1,739,698	)		~~(1,739,698~~	)		-
Interest expense		(~~309~~171,~~784~~256	)		-(99,330	)		~~(590,167~~	)		~~(12,606~~	)
Total other income (expenses)		(~~896~~42,~~106~~191	)		-(1,801,034	)		~~(2,183,171~~	)		~~(12,606~~	)
Loss from continuing operations before income tax provision		(1254,~~059,657~~683	)		(142,~~772~~011,624	)		~~(2,881,043~~	)		~~(267,999~~	)
Income tax provision		-			-			-			-
Loss from continuing operations		(1,059,657	)		(14,772	)		(2,881,043	)		(267,999	)
Loss before income tax provision		(254,683	)		(2,011,624	)
Earnings from discontinued operations net of taxes		-			467,698			-			13,035
Net loss		(254,683	)		(2,011,624	)
Net profit (loss)		(1,059,657	)		452,926			(2,881,043	)		(254,964	)
Series B preferred stock dividend		(9,986	)		(9,986	)
Series B preferred stock dividend		(9,986	)		-			(29,959	)		-
Net loss attributable to common stockholders		(264,669	)		(2,021,610	)
Deemed dividend on Series B convertible preferred stock		-			-			-			(2,397,248	)
Net loss per Common share:
Net profit (loss) attributable to common stockholders		(1,069,643	)		452,926			(2,911,002	)		(2,652,212	)
- Basic and Diluted		(0.11	)		(0.84	)
Net profit (loss) attributable to common stockholders of continuing operations		(1,069,643	)		(14,772	)		(2,911,002	)		(2,665,247	)
Weighted average commons shares Outstanding:
Net profit attributable to common stockholders of discontinuing operations		-			467,698			-			13,035
- Basic and Diluted		2,410,229			2,410,229
Net profit (loss) per common share: Basic EPS
- Continuing operations		(0.11	)		(0.00	)		(0.30	)		(0.28	)
- Discontinuing operations		0.00			0.05			0.00			0.00
- Net profit (loss) per common share		(0.11	)		0.05			(0.30	)		(0.28	)
Net profit (loss) per common share: Diluted EPS
- Continuing operations		(0.11	)		(0.00	)		(0.30	)		(0.28	)
- Discontinuing operations		0.00			0.00			0.00			0.00
- Net profit (loss) per common share		(0.11	)		(0.00	)		(0.30	)		(0.28	)
Weighted average commons shares Outstanding:
- Basic		9,640,915			9,558,686			9,640,915			9,558,686
-Diluted		9,640,915			9,558,686			9,640,915			9,558,686

See accompanying notes to the unaudited consolidated financial statements.

F-2

BRIDGEWAY NATIONAL CORP.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIENCY(UNAUDITED)

FOR THE THREE ~~AND~~MONTH ~~NINE MONTHS~~ ENDED ~~SEPTEMBER~~MARCH 3031, ~~2020~~2021 AND ~~2019~~2020

	Preferred stock Par value $0.001								Common stock Par value $0.001				Additional						Total
	Number of Shares				Amount $				Number		Amount		~~Additional~~ Paid-In Capital			Accumulated Deficit			~~Total~~ Stockholders’ Deficiency
	Series A		Series B		Series A		Series B		of Shares		~~Amount~~ $		~~Capital~~ $			~~Deficit~~ $			~~Deficiency~~ $
Balance, December 31, 2018		1,000		-	$	1		-		9,640,915	$	9,642	$	4,066,644		$	(7,128,606	)	$	(3,052,319	)
Balance, December 31, 2019		1,000		96,429	$	1	$	96		2,410,229	$	2,410	$	6,893,176		$	(6,905,767	)	$	(10,084	)
Preferred stock issued on conversion of convertible notes payable		-		96,429		-		96		-		-		2,397,152			-			2,397,248
Elimination of derivative liability due to debt settlement		-		-		-		-		-		-		461,539			-			461,539
Beneficial conversion feature on convertible preferred stock		-		-		-		-		-		-		2,397,248			-			2,397,248
Deemed dividend on convertible preferred stock		-		-		-		-		-		-		(2,397,248	)		-			(2,397,248	)
Net loss		-		-		-		-		-		-		-		$	(206,927	)	$	(206,927	)
Balance, March 31, 2019		1,000		96,429	$	1	$	96		9,640,915	$	9,642	$	6,925,335		$	(7,335,533	)	$	(400,459	)
Net Loss		-		-		-		-		-		-		-			(500,963	)		(500,963	)
Balance, June 30, 2019		1,000		96,429	$	1	$	96		9,640,915	$	9,642	$	6,925,335		$	(7,836,496	)	$	(901,422	)
Net Profit		-		-		-		-		-		-		-			452,926			452,926
Balance, September 30, 2019		1,000		96,429	$	1	$	96		9,640,915	$	9,642	$	6,925,335		$	(7,383,570	)	$	(448,496	)
Balance, December 31, 2019		1,000		96,429	$	1	$	96		9,640,915	$	9,642	$	6,885,944		$	(6,905,767	)	$	(10,084	)
Preferred stock issued as compensation for financing		-		28,572		-		29		-		-		399,971			-			400,000
Series B Preferred stock dividend		-		-		-		-		-		-		(9,986	)		-			(9,986	)
Deemed distributions to CEO		-		-		-		-		-		-		(155,694	)					(155,694	)
Net loss		-		-		-		-		-		-		-			(2,011,624	)		(2,011,624	)
Balance, March 31, 2020		1,000		125,001	$	1	$	125		92,~~640~~410,~~915~~229	$	92,~~642~~410	$	7,~~120~~127,~~235~~467		$	(8,917,391	)	$	(1,787,388	)
Series B Preferred stock dividend		-		-		-		-		-		-		(9,987	)		-			(9,987	)
Balance, December 31, 2020		1,000		125,001	$	1	$	125		2,410,229	$	2,410	$	7,388,909		$	(11,030,550	)	$	(3,639,105	)
Deemed distributions to CEO		-		-		-		-		-		-		(7,932	)					(7,932	)
Series B Preferred stock dividend		-		-		-		-		-		-	$	(9,986	)		-		$	(9,986	)
Net profit		-		-		-		-		-		-		-			190,238			190,238
Net Loss		-		-		-		-		-		-		-			(254,683	)		(254,683	)
Balance, June 30, 2020		1,000		125,001	$	1	$	125		9,640,915	$	9,642	$	7,102,316		$	(8,727,153	)	$	(1,615,069	)
Balance, March 31, 2021		1,000		125,001	$	1	$	125		2,410,229	$	2,410	$	7,378,923		$	(11,285,233	)	$	(3,903,774	)
Series B Preferred stock dividend		-		-		-		-		-		-		(9,986	)		-			(9,986	)
Beneficial conversion feature on convertible notes payable		-		-		-		-		-		-		108,750			-			108,750
Net loss		-		-		-		-		-		-		-			(1,059,657	)		(1,059,657	)
Balance, September 30, 2020		1,000		125,001	$	1	$	125		9,640,915	$	9,642	$	7,201,080		$	(9,786,810	)	$	(2,575,962	)

See accompanying notes to the unaudited consolidated financial statements.

F-3

BRIDGEWAY NATIONAL CORP.

CONSOLIDATED STATEMENTS OF CASHFLOWS (UNAUDITED)

	For the Nine Months Ended
	For the Three Months Ended
	September 30, 2020			September 30, 2019
	March 31, 2021			March 31, 2020
Cash flows from Operating Activities:
Net loss	$	(2254,~~881,043~~683	)	$	(~~254~~2,~~964~~011,624	)
Less net income from discontinued operations		-			(13,035	)
Net loss from continuing operations		(2,881,043	)		(267,999	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expenses		72,~~199~~337			~~234~~1,958
Interest expense on convertible notes		-			~~12,606~~-
Initial recognition of loss of derivative liabilities		~~1,739,698~~-			-1,739,698
Interest expense accretion of convertible notes discount		~~581~~91,~~972~~222			-99,330
Change in fair value of derivative liabilities		(~~146~~129,~~694~~065	)		-(37,994	)
Non cash operating lease expense		~~118~~39,~~160~~386			-39,387
Changes in Operating Assets and Liabilities:
Prepaid expense		-			(9017,~~000~~244	)
Due from related parties		6,661			(26,530	)
Security Deposits					(66,155	)
Accounts payable and accrued expenses		(23,152	)		27,431
Due from related parties		(11,374	)		(70,697	)
Accrued interest		8,195			-
Accounts payable and accrued expenses		185,443			(21,151	)
Right of use liabilities		(7829,~~774~~998	)		-(25,482	)
Net cash used in operating activities - continued operations		(667,778	)		(344,258	)
Net cash used in operating activities		(106,732	)		(369,974	)
Net cash used in operating activities - discontinued operations		-			(1,479,563	)
Net cash used in operating activities		(667,778	)		(1,823,821	)
Cash flows from Investing Activities:
Purchases of property and equipment		~~(84,906~~-	)		(466,~~686~~378	)
Net cash used in investing activities - continued operations		(84,906	)		(4,686	)
Net cash used in investing activities		-			(66,378	)
Net cash used in investing activities - discontinued operations		-			(30,317,545	)
Net cash used in investing activities		(84,906	)		(30,322,231	)
Cash flows from Financing Activities:
Proceeds from convertible notes		900,000			-
Proceeds from notes payable		150,000			-
Net cash provided by financing activities - continued operations		900,000			-
Proceeds from convertible notes		45,000			750,000
Net cash provided by financing activities - discontinued operations		-			33,820,020
Net cash provided by financing activities		195,000			750,000
Net cash provided by financing activities		900,000			33,820,020
Net Change in Cash		88,268			313,648
Net Change in Cash		147,316			1,673,968
Cash - Beginning of Reporting Period		1,915			-
Cash - Beginning of Reporting Period		-			-
Cash - End of Reporting Period	$	90,183		$	313,648
Cash - End of Reporting Period	$	147,316		$	1,673,968
Supplemental Disclosure of Cash Flow Information
Interest paid		-			500,961
Interest Paid		-			-
Income tax paid		-			-
Initial recognition of beneficial conversion feature		108,750			-
Issuance of Series B preferred stock as compensation for deferred financing fees		-			400,000
Issuance of Series B preferred stock as compensation for deferred financing fees		400,000			-
Dividends declared on series B preferred stock		9,986			9,986
Issuance of Series B preferred stock for settlement of convertible notes payable		-			2,397,248
Right of use assets and right of use liabilities recognized		-			879,635
Elimination of derivative liability due to debt settlement		-			461,539
Initial recognition of debt discount		-			845,000
Dividends declared on series B preferred stock		29,959			-
Deemed distribution to CEO		-			155,694
Right of use assets and right of use liabilities recognized		879,635			-
Initial recognition of debt discount		850,000			-
Deemed distribution to CEO		163,626			-

See accompanying notes to the unaudited consolidated financial statements.

F-4

BRIDGEWAY NATIONAL CORP.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

FOR THE THREE ~~AND NINE~~ MONTHS ENDED ~~SEPTEMBER~~MARCH 3031, ~~2020~~2021

Note 1 - Organization and Operations

Bridgeway National Corp., which we refer to as “the Company,” “our Company,” “we,” “us” or “our,”‎ was originally incorporated under the laws of the State of Nevada as Snap Online Marketing Inc. on June 4, 2012 and subsequently changed its name to LifeLogger Technologies Corp., which we were referred to as “LifeLogger.” On April 10, 2019, we reincorporated as a Delaware corporation and changed our name to Capital Park Holdings Corp. On December 19, 2019, we changed our name to Bridgeway National Corp. Our principal business address is 1015 15^th Street NW Suite 1030, Washington, DC 20005, 202-846-7869. We registered as a reporting company under the Securities Exchange Act of 1934, as amended on April 26, 2013. We are currently listed for trading on the OTC Pink under the trading symbol “BDGY.”

Corporate Structure

The Company is structured as a Delaware corporation that we expect to be treated as a corporation for U.S. federal income tax purposes. Your rights as a holder of shares, and the fiduciary duties of the Company’s Board of Directors and executive officers, and any limitations relating thereto are set forth in the documents governing the Company and may differ from those applying to a Delaware corporation. However, the documents governing the Company specify that the duties of its directors and officers will be generally consistent with the duties of a director of a Delaware corporation. The Company’s Board of Directors will oversee the management of the Company and our businesses. Initially, the Company’s Board of Directors will be comprised of five (5) directors, with three (3) of those directors appointed by holders of the Company’s Class A common stock and two (2) of those directors appointed by holders of the Company’s Class B common stock, and at least three (3) of whom will be the Company’s independent directors.

Prior to the transactions that took place on January 9, 2019, we were a lifelogging software company that developed and hosted a proprietary cloud-based software solution ‎accessible on iOS and Android devices that offers an enhanced media experience for consumers by augmenting ‎videos, livestreams and photos with additional context information and providing a platform that makes it easy to ‎find and use that data when viewing or sharing media. Subsequent to transactions that took place on January 9, 2019, in addition to its lifelogging software business, the Company has been structured as a holding company ‎with a business strategy focused on owning subsidiaries engaged in a number of diverse business activities.‎

F-5

Note 2 - Summary of Significant Accounting Policies

Reclassification

Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. These reclassifications had no effect on the previously reported net loss.

Liquidity and Basis of Presentation

The accompanying unaudited consolidated financial statements are expressed in United States dollars (“USD”) and related ~~Notes~~ Notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited consolidated financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to present a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of the results for the full fiscal year. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the year ended December 31, ~~2019~~2020 and notes thereto contained in the information as part of the Company’s Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission on ~~September 21~~June 1, ~~2020~~2021.

The unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

As reflected in the unaudited consolidated financial statements, the Company had an accumulated deficit of $911,~~786~~285,~~810~~233 at ~~September~~March 31, 302021, ~~2020,~~ and a net loss of $2254,~~881,043~~683 for the ~~nine~~three-month ended ~~September~~March 3031, ~~2020~~2021. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

Although the Company has recently broadened its business and operating model in an effort to generate more sufficient and stable sources of revenues and cash flows, its cash position is not sufficient to support its daily operations. While the Company believes that its new business and operating model presents a viable strategy to generate sufficient revenue and believes in its ability to raise additional funds by way of a public or private offering, there can be no assurances to that effect.

The unaudited consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary if the Company is unable to continue as a going concern.

F-6

~~Leases~~Note 3 – Notes Payable and Convertible Notes Payable

On January 1, 2019, the Company adopted Accounting Standards Codification Topic 842, “Leases” (“ASC 842”) to replace existing lease accounting guidance. This pronouncement is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet for most leases. Expenses associated with leases will continue to be recognized in a manner similar to previous accounting guidance. The Company adopted ASC 842 utilizing the transition practical expedient added by the Financial Accounting Standards Board (“FASB”), which eliminates the requirement that entities apply the new lease standard to the comparative periods presented in the year of adoption.

Convertible Notes Issue Date	Interest Rate			March 31, 2021 Principal Balance
March 2, 2020		12	%	$	845,000
September 30, 2020		6	%	$	155,000
October 3, 2020		6	%	$	155,000
October 23, 2020		9	%	$	68,000
November 16, 2020		9	%	$	48,000
January 20, 2021		9	%	$	48,000
Total				$	1,319,000

The ~~Company~~weighted isaverage ~~the~~interest ~~lessee~~rate inand aremaining ~~lease~~term ~~contract~~of ~~when~~ the ~~Company~~fixed ~~obtains~~rate ~~the~~convertible ~~right~~notes topayable ~~use~~is ~~the~~10% ~~asset~~and 4.74 ~~Operating~~months ~~leases are included in~~as ~~the line items right-~~of~~-use~~ ~~asset~~March ~~right of use liabilities – operating leases~~31, ~~current, and right of use liabilities – operating leases, long-term in the balance sheet~~2021.

Right-of-use (“ROU”) asset represents the Company’s right to use an underlying asset for the lease term and lease obligations represent the Company’s obligations to make lease payments arising from the lease, both of which are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. Leases with a lease term of 12 months or less at inception are not recorded on the balance sheet and are expensed on a straight-line basis over the lease term in our consolidated statements of operations. The Company determines the lease term by agreement with lessor. As our lease do not provide an implicit interest rate, the Company uses the Company’s incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. Refer to Note 10 for further discussion.

Notes Payable Issue Date	Interest Rate			March 31, 2021 Principal Balance
March 24, 2021		3.75	%	$	150,000
Total				$	150,000

~~Convertible~~The ~~Notes~~movement ~~Payable~~in notes payable and ~~Derivative~~convertible ~~Instruments~~notes payable is as follows:

The Company has adopted the provisions of ASU 2017-11 to account for the down round features of warrants issued with private placements effective as of April 1, 2017. In doing so, warrants with a down round feature previously treated as derivative liabilities in the balance sheet and measured at fair value are henceforth treated as equity, with no adjustment for changes in fair value at each reporting period. Previously, the Company accounted for conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them as free-standing derivative financial instruments. ASC 815 provides for an exception to this rule when convertible notes, as host instruments, are deemed to be conventional, as defined by ASC 815-40. The Company accounts for convertible notes deemed conventional and conversion options embedded in non-conventional convertible notes which qualify as equity under ASC 815, in accordance with the provisions of ASC 470-20, which provides guidance on accounting for convertible securities with beneficial conversion features. Accordingly, the Company records, as a discount to convertible notes, the intrinsic value of such conversion options based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt.

		Original Amount		Unamortized Discount			Guaranteed Interest Accrued		Total
Issued: March 2, 2020	(ii)		845,000		-			142,368	$	987,368
Issued: September 30, 2020	(ii)		155,000		(37,917	)		4,612	$	121,695
Issued October 3, 2020	(ii)		155,000		(52,241	)		4,612	$	107,371
Issued: October 23, 2020	(iii)		68,000		(1,693	)		2,210	$	68,517
Issued: November 16, 2020	(iii)		48,000		(1,890	)		2,025	$	48,135
Issued: January 20, 2021	(iii)		48,000		(2,425	)		1,053	$	46,628
Issued: March 24, 2021	(iv)		150,000		-			-	$	150,000
Ending as of March 31,2021		$	1,469,000		(96,166	)		156,880	$	1,529,714

If the conversion feature and other features embed within the convertible note meets the requirements to be treated as a derivative, we estimate the fair value of the convertible debt derivative using the valuation technique upon the date of issuance. If the fair value of the convertible debt derivative is higher than the face value of the convertible note, the excess is immediately recognized as interest expense. Otherwise, the fair value of the convertible note derivative is recorded as a liability with an offsetting amount which offsets the carrying amount of the note. The convertible debt derivative is revalued at the end of each reporting period on a recurring basis and any change in fair value is recorded as a gain or loss in the consolidated statements of operations. The note discount is amortized through interest expense over the life of the note.

F-7

~~Note~~(i) 2Securities -Purchase ~~Summary~~Agreement ofand ~~Significant~~Convertible ~~Accounting~~Notes ~~Policies~~Issued ~~(continued)~~to Calvary Fund I, LP; Oasis Capital, LLC and SBI Investments LLC

~~Recently~~On March 2, 2020 (the “Issue Date”), the Company entered into an unsecured promissory note purchase agreement with SBI, on behalf of itself and the other note purchasers (the “Note Purchasers”), pursuant to which the Note Purchasers purchased from the Company (a) 12% convertible promissory notes of the Company in an aggregate principal amount of $845,000 (the “12% Notes”) of which $75,000 were related to original issuance discount and $20,000 were related to deferred finance costs (with the understanding that the initial six months of such interest shall be guaranteed) (together with any note(s) issued ~~accounting~~in ~~pronouncements~~replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms thereof, the “Notes”, and each, a “Note”), convertible into shares (the “Conversion Shares”) of common stock of the Company (the “Common Stock”) and (b) warrants (the “Warrants”) to acquire up to 1,111,842 Shares subject to a beneficial ownership cap of no greater than 4.99% in the case of each Purchaser (the “Warrant Shares”).

~~In July~~The ~~2019,~~maturity ~~the~~date ~~FASB~~of ~~issued~~the ~~ASU~~12% ~~2019-07,~~Notes ~~Codification~~shall ~~Updates~~be toon ~~SEC~~that ~~Sections.~~day ~~This~~that ~~ASU~~is nine ~~amends~~(9) ~~various~~months ~~SEC~~after ~~paragraphs pursuant to~~ the ~~issuance~~Issue ofDate ~~SEC~~(the ~~Final~~“Maturity ~~Rule~~Date”) ~~Releases No. 33-10532, Disclosure Update~~ and ~~Simplification,~~is ~~and~~the ~~Nos.~~date ~~33-10231~~upon ~~and~~which ~~33-10442, Investment Company Reporting Modernization. One of~~ the ~~changes~~principal inamount ~~the ASU requires a presentation~~ of ~~changes in stockholders’ equity in~~ the ~~form~~12% ~~of a reconciliation~~Notes, as ~~either~~well as aall ~~separate~~accrued ~~financial~~and ~~statement~~unpaid orinterest inand ~~the~~other ~~notes to the financial statements~~fees, ~~for~~ ~~the~~shall ~~current~~be due and ~~comparative year-to-date interim periods~~payable. The ~~Company~~notes ~~presented~~are ~~changes~~currently in ~~stockholders’~~Default ~~equity~~status asat ~~separate financial~~a ~~statements for the current and comparative year-to-date interim periods beginning on January 1, 2020. The additional~~rate ~~elements~~ of ~~the~~24% ~~ASU~~which ~~did~~has ~~not~~been ~~have a material impact on the Company’s consolidated financial statements~~accrued.

InAs ~~December~~at ~~2019,~~March ~~the FASB issued ASU No. 2019-12~~31, ~~Simplifying~~2021 the ~~Accounting~~Company ~~for~~owed ~~Income Taxes (“ASU 2019-12”)~~$845,000 ~~which simplifies~~in ~~the~~principal ~~accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes,~~ and ~~clarifies certain aspects of~~ the ~~current~~accrued ~~guidance~~interest towas ~~promote consistency among reporting entities. ASU 2019-12 is effective for fiscal years beginning after December 15~~$142, ~~2021. Most amendments within the standard are required to be applied on a prospective basis~~368, ~~while~~which ~~certain amendments~~consisted ~~must be applied on a retrospective or modified retrospective basis. The Company is currently evaluating the impacts~~ of ~~the~~accrued ~~provisions of ASU 2019-12 on its financial condition, results of operations,~~ interest and ~~cash~~default ~~flows~~interest.

In(ii) ~~March~~On ~~2020~~September 30, 2020 (the ~~FASB~~“Issue ~~issued~~Date”), ~~ASU~~the ~~No.~~Company ~~2030-20~~entered ~~Codification~~into ~~Improvements~~an tounsecured ~~Financial~~promissory ~~Instruments,~~note Anpurchase ~~Amendment~~agreement ofwith ~~the~~SBI, on ~~FASB~~behalf ~~Accounting Standards~~of ~~Codification:~~itself ~~a)in~~and ~~ASU~~the ~~No.~~other ~~2016-01,~~note b)purchasers in(the ~~Subtopic~~“Note ~~820-10~~Purchasers”), c)pursuant ~~for~~to ~~depository~~which ~~and~~the ~~lending~~Note ~~institutions~~Purchasers ~~clarification~~purchased infrom ~~disclosure~~the ~~requirements,~~Company d(a) intwo ~~Subtopic~~6% ~~470-50,~~convertible e)promissory innotes ~~Subtopic 820-10~~($155,000 feach) ~~Interaction~~ of ~~Topic~~the ~~842~~Company ~~and~~in ~~Topic~~an ~~326,~~aggregate g)principal ~~Interaction~~ amount of $310,000 (the ~~guidance~~“6% inNotes”) ~~Topic~~convertible ~~326~~into ~~and~~Shares ~~Subtopic~~(the ~~860-20.The~~“Conversion ~~amendments~~Shares”) insubject ~~this~~to ~~Update~~a ~~represent~~beneficial ~~changes~~ownership tocap ~~clarify~~of orno greater ~~improve~~than ~~the Codification~~4. ~~The~~99% ~~amendments~~in ~~make~~ the ~~Codification~~case ~~easier~~of toeach ~~understand~~Purchaser. ~~and~~Pursuant ~~easier~~ to ~~apply by eliminating inconsistencies and providing clarifications. For public business entities updates under~~ the ~~following paragraphs: a)~~agreement, ~~b),~~each d)note ~~and~~was e)issued ~~are~~with ~~effective~~an ~~upon~~original ~~issuance~~issue ofdiscount ~~this final~~of ~~update.~~$5,000 ~~The~~and ~~effective~~as ~~date~~such ~~for~~the c)purchase isprice ~~for~~was ~~fiscal years beginning after December 15~~$150, ~~2019, including interim periods within those fiscal years~~000. The ~~Company~~proceeds ~~does~~of ~~not~~one ~~expect~~note ~~that~~was ~~the~~received ~~new~~on ~~guidance~~October ~~will~~3, ~~significantly impact its consolidated financial statements~~2020.

The maturity date of ~~Company~~the ~~continues~~6% toNotes ~~evaluate~~shall be on that day that is nine (9) months after the ~~impact~~Issue ofDate (the ~~new~~“Maturity ~~accounting~~Date”) ~~pronouncement,~~and ~~including~~is ~~enhanced~~the ~~disclosure~~date ~~requirements~~upon which the principal amount of the 6% Notes, onas ~~our business~~well ~~processes~~as all accrued and unpaid interest and other fees, ~~controls~~shall be due and ~~systems~~payable. The notes also carry a default rate of 18%.

F-8

~~Note~~As 3at –March ~~Property~~31, 2021 the Company owed $310,000 in principal and ~~Equipment~~the accrued interest was $9,224. The debenture is convertible into common shares of the Company at a conversion price $0.16. The convertible debt was not considered tainted due to 5,812,500 shares of common stock held on reserve for issuance upon full conversion of this debenture. The Company evaluated the convertible notes for a beneficial conversion feature in accordance with ASC 470-20 “Debt with Conversion and Other Options.” The Company determined that the conversion price was below the closing stock price on the commitment date, and the convertible notes contained a beneficial conversion feature. The Company recognized the intrinsic value of the embedded beneficial conversion feature of $258,750 as additional paid-in capital and reduced the carrying value of the convertible notes to $41,250. The carrying value will be accreted over the term of the convertible notes up to their face value of $310,000.

~~Property~~As ~~and~~at ~~equipment~~March as31, at2021, ~~September~~the 30carrying value of the 6% Note was $219,842 ~~2020~~and ~~consisted~~had an unamortized discount of ~~the~~$90,158 ~~following:~~($86,806 beneficial conversion feature and $3,352 OID).

	September 30, 2020 $			December 31, 2019 $
Computer and equipment		23,214			4,686
Office equipment		66,378			-
		89,592			4,686
Accumulated depreciation		(7,902	)		(703	)
Total		81,690			3,983

(iii) Securities Purchase Agreement and Convertible Notes Issued to Geneva Roth Remark Holdings, Inc.

On October 23, 2020 (the “Issue Date”), the Company entered into an unsecured promissory note purchase agreement with Geneva Roth Remark Holdings, Inc. (the “Note Purchaser”), pursuant to which the Note Purchaser purchased from the Company (a) the 9% convertible promissory note of the Company in an aggregate principal amount of $68,000 ($3,000 OID) (the “9% Note”) convertible into Shares (the “Conversion Shares”) subject to a beneficial ownership cap of no greater than 4.99% –in ~~Convertible~~the ~~Notes~~case ~~Payable~~of the Purchaser (the “Maximum Share Amount”). The maturity date of the 9% Note shall be on October 23, 2021 (the “Maturity Date”) and is the date upon which the principal amount of the 9% Note, as well as all accrued and unpaid interest and other fees, shall be due and payable. The Note also has a 22% default interest rate. The “Conversion Price” shall be equal to the Variable Conversion Price (as defined below) (subject to equitable adjustments for stock splits, stock dividends or rights offerings by the Company relating to the Company’s securities or the securities of any subsidiary of the Company, combinations, recapitalization, reclassifications, extraordinary distributions and similar events). The “Variable Conversion Price” shall mean 65% multiplied by the Market Price (as defined below) (representing a discount rate of 35%). “Market Price” means the average of the three (3) lowest trading prices) for the shares during the fifteen (15) trading day period ending on the latest complete trading day prior to the Conversion Date

a)As at On March 231, ~~2020~~2021 (the ~~“Issue Date”), the~~ Company ~~entered~~owed ~~into a promissory note purchase agreement (the “Purchase Agreement”) with SBI Investments LLC~~$68,000 2014-1, a statutory series of Delaware limited liability company (the “Purchaser” or “SBI”), on behalf of itself and the other note purchasers (collectively, the “Purchasers”), pursuant to which the Purchasers purchased from the Company (i) 12% unsecured convertible promissory notes of the Company in ~~an aggregate~~ principal ~~amount of $845,000 of which $75,000 were related to original issuance discount~~ and ~~$20,000 were related to deferred finance costs (with~~ the ~~understanding~~accrued ~~that the initial six months of such~~ interest ~~shall~~was be$2,210 ~~guaranteed) (together~~ with ~~any~~unamortized ~~note(s)~~debt ~~issued~~discount in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms thereof, the “Notes”, and each, a “Note”), convertible into shares (the “Conversion Shares”) of ~~common stock of the Company (the “Common Stock”) and (ii) warrants (each a “Warrant” and together~~ $1, ~~the “Warrants”) to acquire up to 4,447,368 shares of Common Stock (the “Warrant Shares”)~~693. ~~The maturity date of the notes is December 2, 2020 (the “Maturity Date”).~~

Under the terms of the Notes, the Purchasers shall have the right at any time on or after the Issue Date, to convert (a “Conversion”) all or any part of the outstanding and unpaid principal amount and accrued and unpaid interest of the Notes, and any other amounts owed under the Notes, into shares of Common Stock at the Conversion Price (as defined below). However, in no event shall any Purchaser be entitled to convert any portion of any of the Notes in excess of the amount that upon conversion would result in the number of shares of Common Stock beneficially owned by the Purchaser and its affiliates to exceed 4.99% of the outstanding shares of Common Stock (the “Maximum Share Amount”). The “Conversion Price” per share is the lower of (i) $0.095 or (ii) the Variable Conversion Price (as defined below). The “Variable Conversion Price” shall mean 70% multiplied by the Market Price (as defined below). “Market Price” means the lowest trading price for the Common Stock during the fifteen (15) day period ending on the last complete trading day prior to the Conversion Date.

Under the terms of the Warrants, the exercise price per share of the Common Stock under each Warrant shall be equal to $0.095 per share, subject to adjustment (the “Exercise Price”) and each Warrant contains a cashless exercise option. Each Warrant has a term of five (5) years from the Issue Date.

The Notes and Warrants included embedded derivative features that were accounted for as derivative liabilities due to the variable conversion prices upon default and forced conversion; full reset provisions; and redemption features based on FASB guidance in ASC 815 and EITF 07–05. The Warrants were treated as derivative liabilities due to the tainted equity environment based on the notes that are convertible into an indeterminate number of shares. On March 2, 2020, the Company recorded an initial recognition loss of derivative liabilities of $1,739,698, $750,000 discount on the notes payable of which $50,700 is 6-months guaranteed interest and $95,000 original issuance discount amortized over the term of the convertible notes. The amount of amortization recognized on the discount for the three-and nine-month period ended was $301,589 ($309,784 less $8,195 accrued interest) and $581,972 ($590,167 less $8,195 accrued interest), respectively.

As at September 30, 2020 the Company owed $845,000 in principal and the accrued interest was $58,895, which consisted of the guaranteed interest accrued of $50,700 and was recorded in accrued expenses on convertible notes.

b) On September 30, 2020, the Company issued a convertible debenture, to a non-related party, in the amount of $155,000. Pursuant to the agreement, the note was issued with an original issue discount of $5,000 and as such the purchase price was $150,000. Under the terms of the debenture, the amount is unsecured, bears interest at 6% per annum (18% default interest rate), and is due on June 30, 2021. The debenture is convertible into common shares of the Company at a conversion price $0.04. The convertible debt was not considered tainted due to 11,625,000 shares of common stock held on reserve for issuance upon full conversion of this debenture. The Company evaluated the convertible notes for a beneficial conversion feature in accordance with ASC 470-20 “Debt with Conversion and Other Options.” The Company determined that the conversion price was below the closing stock price on the commitment date, and the convertible notes contained a beneficial conversion feature. The Company recognized the intrinsic value of the embedded beneficial conversion feature of $108,750 as additional paid-in capital and reduced the carrying value of the convertible note to $41,250. The carrying value will be accreted over the term of the convertible notes up to their face value of $155,000.

As at September 30, 2020, the carrying value of the convertible note was $41,250 and had an unamortized discount of $113,750 ($108,750 beneficial conversion feature and $5,000 OID). During the nine-month period ended September 30, 2020, the Company recorded accretion expense of $nil.

F-9

On November 16, 2020 (the “Issue Date”), the Company entered into an unsecured promissory note purchase agreement with Geneva Roth Remark Holdings, Inc. (the “Note Purchaser”), pursuant to which the Note Purchaser purchased from the Company (a) the 59% –convertible ~~Derivative~~promissory ~~Liability~~note of the Company in an aggregate principal amount of $48,000 ($3,000 OID) (the “9% Note II”) convertible into Shares (the “Conversion Shares”) subject to a beneficial ownership cap of no greater than 4.99% in the case of the Purchaser (the “Maximum share Amount”). The maturity date of the 9% Note II shall be on November 16, 2021 (the “Maturity Date”) and is the date upon which the principal amount of the 9% Note, as well as all accrued and unpaid interest and other fees, shall be due and payable. The Note also has a 22% default interest rate. The “Conversion Price” shall be equal to the Variable Conversion Price (as defined below) (subject to equitable adjustments for stock splits, stock dividends or rights offerings by the Company relating to the Company’s securities or the securities of any subsidiary of the Company, combinations, recapitalization, reclassifications, extraordinary distributions and similar events). The “Variable Conversion Price” shall mean 65% multiplied by the Market Price (as defined below) (representing a discount rate of 35%). “Market Price” means the average of the three (3) lowest trading prices) for the shares during the fifteen (15) trading day period ending on the latest complete trading day prior to the Conversion Date

As at March 31, 2021 the Company owed $48,000 in principal and the accrued interest was $2,025 with unamortized debt discount of $1,890.

On January 20, 2021 (the “Issue Date”), the Company entered into an unsecured promissory note purchase agreement with Geneva Roth Remark Holdings, Inc. (the “Note Purchaser”), pursuant to which the Note Purchaser purchased from the Company (a) the 9% convertible promissory note of the Company in an aggregate principal amount of $48,000 ($3,000 OID) (the “9% Note III”) convertible into Shares (the “Conversion Shares”) subject to a beneficial ownership cap of no greater than 4.99% in the case of the Purchaser (the “Maximum share Amount”). The maturity date of the 9% Note III shall be on January 20, 2022 (the “Maturity Date”) and is the date upon which the principal amount of the 9% Note, as well as all accrued and unpaid interest and other fees, shall be due and payable. The Note also has a 22% default interest rate. The “Conversion Price” shall be equal to the Variable Conversion Price (as defined below) (subject to equitable adjustments for stock splits, stock dividends or rights offerings by the Company relating to the Company’s securities or the securities of any subsidiary of the Company, combinations, recapitalization, reclassifications, extraordinary distributions and similar events). The “Variable Conversion Price” shall mean 65% multiplied by the Market Price (as defined below) (representing a discount rate of 35%). “Market Price” means the average of the three (3) lowest trading prices) for the shares during the fifteen (15) trading day period ending on the latest complete trading day prior to the Conversion Date

As at March 31, 2021 the Company owed $48,000 in principal and the accrued interest was $1,053 with unamortized debt discount of $2,425.

(iv) Notes issued to the Small Business Administration

On March 24, 2021, Bridgeway was approved for a SBA Loan-2 in the amount of $150,000. SBA Loan-2, interest will accrue at the rate of 3.75% per annum with installment payments, including principal and interest, of $731.00 per month beginning on the twelve (12) month anniversary of the funding date. The balance of principal and interest will be payable on the thirty (30) year anniversary of the funding date.

F-10

Note 4 – Derivative Liability

In connection with the sale of debt or equity instruments, the Company may sell warrants to purchase the Company’s common stock. In certain circumstances, these warrants may be classified as derivative liabilities, rather than as equity. Additionally, the debt or equity instruments may contain embedded derivative instruments, such as embedded derivative features which in certain circumstances may be required to be bifurcated from the associated host instrument and accounted for separately as a derivative instrument liability.

The Company’s derivative instrument liabilities are re-valued at the end of each reporting period, with changes in the fair value of the derivative liability recorded as charges or credits to income in the period in which the changes occur. For warrants and bifurcated embedded derivative features that are accounted for as derivative instrument liabilities, the Company estimates fair value using either quoted market prices of financial instruments with similar characteristics or other valuation techniques. The valuation techniques require assumptions related to the remaining term of the instruments and risk-free rates of return, the Company’s current common stock price and expected dividend yield, and the expected volatility of the Company’s common stock price over the life of the instrument.

The following table summarizes the warrant derivative liabilities and convertible notes activity for the ~~nine~~three months ended ~~September~~March 3031, ~~2020~~2021:

	Derivative Liabilities
Derivative liabilities as at December 31, 2019		-
Derivative liabilities as at December 31, 2020	$	1,717,337
Initial recognition of loss of derivative liabilities	$	1,739,698
Change in fair value of warrants and notes		(129,065	)
Convertible notes discount		699,300
Derivative liabilities as at March 31, 2021	$	1,588,272
Change in fair value of warrants and notes		(37,994	)
Derivative liabilities as at March 31, 2020	$	2,401,004
Change in fair value of warrants and notes		(695,022	)
Derivative liabilities as at June 30, 2020	$	1,705,982
Change in fair value of warrants and notes		586,322
Derivative liabilities as at September 30, 2020	$	2,292,304

The Monte Carlo methodology was used to value the derivative components, using the following assumptions:

	Warrants			Notes
Dividend yield		-			12	%
Risk-free rate for term		~~1.05% to~~ 0.3135	%		0.~~97% - 0.13~~03	%
Volatility		~~288~~342.~~6% to 323.~~3	%		~~286~~393.~~5% to 348.1~~9	%
Remaining term (Years)		43.4292			0.1725
Stock Price	$	0.~~040 to $0.110~~0373		$	0.~~040 to $0.110~~0373

F-1011

Note 65 – Fair Value of Financial Instruments

The Company’s financial instruments consist of cash and cash equivalents, accounts payable and accrued expenses, derivative liabilities and convertible debt. The estimated fair value of the financial instruments approximate their carrying amounts due to the short-term nature of these instruments.

The Company utilizes various types of financing to fund its business needs, including convertible debt with warrants attached. The Company reviews its warrants and conversion features of securities issued as to whether they are freestanding or contain an embedded derivative and, if so, whether they are classified as a liability at each reporting period until the amount is settled and reclassified into equity with changes in fair value recognized in current earnings. The fair value of the warrants and the embedded conversion feature of the convertible debt is classified as a liability. Some of these units have embedded conversion features that are treated as a discount on the convertible notes. Such financial instruments are initially recorded at fair value and amortized to interest expense over the life of the debt using the effective interest method.

Inputs used in the valuation to derive fair value are classified based on a fair value hierarchy which distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs). The hierarchy consists of three levels:

Level one - Quoted market prices in active markets for identical assets or liabilities;

Level two - Inputs other than level one inputs that are either directly or indirectly observable; and

Level three - Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company’s derivative liability is measured at fair value on a recurring basis. The Company classifies the fair value of these convertible notes and warrants derivative liability under level three. The Company’s settlement payable is measured at fair value on a recurring basis based on the most recent settlement offer. The Company classifies the fair value of the settlement payable under level three. The Company’s rescission liability is measured at fair value on a recurring basis based on the most recent stock price. The Company classifies the fair value of the rescission liability under level one.

Based on ASC Topic 815 and related guidance, the Company concluded the common stock purchase warrants are required to be accounted for as derivatives as of the issue date due to a reset feature on the exercise price. At the date of issuance warrant derivative liabilities were measured at fair value using either quoted market prices of financial instruments with similar characteristics or other valuation techniques. The Company records the fair value of these derivatives on its balance sheet at fair value with changes in the values of these derivatives reflected in the consolidated statements of operations as “Change in fair value of derivative liabilities” These derivative instruments are not designated as hedging instruments under ASC 815-10 and are disclosed on the balance sheet under Derivative Liabilities.

The following table presents liabilities that are measured and recognized at fair value on a recurring and non-recurring basis:

Description	Level 1		Level 2		Level 3		~~Gains~~
Derivatives	$	-	$	-	$	-1,717,337	$	-
Fair Value at December 31, 2019	$	-	$	-	$	-	$	-
Fair Value at December 31, 2020	$	-	$	-	$	1,717,337
Derivatives	$	-	$	-	$	21,~~292~~588,~~304~~272	$	~~146,694~~
Fair Value at September 30, 2020	$	-	$	-	$	2,292,304	$	146,694
Fair Value at March 31, 2021	$	-	$	-	$	1,588,272

Note 7 – Warrants:

As at September 30, 2020, the Company had the following warrant securities outstanding:

	Common Stock Warrants
January 1, 2020		-
Less: Exercised		-
Less: Expired/Cancelled		-
Add: Issued		10,562,499	*
September 30, 2020		10,562,499

*The amount of warrants as at March 31, 2020 and June 30, 2020 was 4,447,368. As at September 30, 2020, the number of warrants outstanding included a full reset adjustment due to the issuance of additional convertible notes.

The fair value of the warrants at issuance was $577,868, with an expiration of March 3, 2025 and exercise price of $0.095. During the three months ended September 30, 2020, the exercise price was reset to $0.04. The fair value of the warrants as at September 30, 2020 was $803,192.

F-11

Note 8 – Related Party Transactions

Related Parties

Related parties with whom the Company had transactions are:

Related Parties		Relationship
Stew Garner		Chairman, CEO, CFO and director (resigned effective January 9, 2019)
Eric Blue		Chairman, CEO, and director (effective January 9, 2019)

Consulting services from Officer

Consulting services provided by the officer for the nine months ended September 30, 2020 and 2019:

		September 30, 2020				September 30, 2019
President, Chief Executive Officer and Chief Financial Officer		$	nil			$	nil

During the year ended December 31, 2019, an amount of $113,070 of payments were made on behalf of a related company by virtue of same management. The amount of $84,997 due to related party as of December 31, 2019 were unsecured, bore no interest and were due on demand. Included in the amount were $28,073 in dividends paid by the related party on behalf of the Company as of December 31,2019.

During the nine-month ended September 30, 2020, an amount of $163,626 were characterized as a deemed distribution to the CEO; an amount of $78,629 of advances and $85,290 of payments were made to the CEO. Included in accounts payable was a balance of $85,290 owing to the current CEO of the Company as of September 30, 2020, which were unsecured, bore no interest and were due on demand.

Note 9- Stockholders’ Deficiency

Shares Authorized

The Company’s authorized capital stock consists of 168,750,000 shares of Class A common stock, par value $0.001 per share, 18,750,000 Class B common stock, par value $0.001per share and 62,500,000 shares of preferred stock, par value $0.001 per share of which 1,000 shares are designated “Series A Preferred Stock” and of which one hundred twenty-five thousand and one hundred eighty-one (125,181) shares are designated “Series B Preferred Stock”.

Common Stock

Common Shares Issued for Cash

No common shares were issued for cash during the nine months ended September 30, 2020.

Common Shares Issued for Non- Cash

No common shares were issued for non-cash during the nine months ended September 30, 2020.

Preferred Stock

During the nine-month period ended September 30, 2020, the Company declared $29,959 in dividends on the Series B Preferred Stock, of which $29,959 was accrued as Dividend Payable.

On October 24, 2019, the Company entered into an equity purchase agreement (the “Purchase Agreement”) with SBI and Oasis Capital, LLC, a Puerto Rico limited liability company (“Oasis” and together with SBI, the “Investors”, and each, an “Investor”), pursuant to which the Investors agreed to, in the aggregate between the Investors, purchase from the Company up to Ten Million Dollars ($10,000,000.00)(the “Maximum Commitment Amount”) of the Common Stock.

F-12

Note 9-6 ~~Stockholders’~~– ~~Deficiency~~Stock ~~(continued)~~Options and Warrants:

~~Under~~As ~~the~~at ~~terms~~March ~~of the Purchase Agreement~~31, the Company shall have the right, but not the obligation, to direct an Investor, by its delivery to the Investor of a put notice (the “Put Notice”) from time to time beginning on the execution date of the Purchase Agreement and ending on the earlier to occur of: (i) the date on which the Investors shall have purchased Put Shares equal to the Maximum Commitment Amount, (ii) October 24, 2021, ~~or (iii) written notice of termination by~~ the Company tohad the ~~Investors~~following ~~(together, the~~warrant ~~“Commitment~~securities ~~Period”), to purchase Put Shares.~~outstanding:

Notwithstanding any other terms of the Purchase Agreement, in each instance, (i) the amount that is the subject of a Put Notice (the “Investment Amount”) is not more than the Maximum Put Amount (as defined below), (ii) the aggregate Investment Amount of all Put Notices shall not exceed the Maximum Commitment Amount and (iii) the Company cannot deliver consecutive Put Notices and/or consummate closings to the same Investor, meaning for the avoidance of doubt, that Put Notices delivered by the Company must alternate between Oasis and SBI. “Maximum Put Amount” means the lesser of (i) such amount that equals two hundred fifty percent (250%) of the average daily trading volume of the Common Stock and (ii) One Million Dollars ($1,000,000.00). The price paid for each share of Common Stock (the “Purchase Price”) subject to a Put Notice (each, a “Put Share”) shall be 85% of the Market Price (as defined below) on the date upon which the Purchase Price is calculated in accordance with the terms and conditions of the Purchase Agreement. “Market Price” means the one (1) lowest traded price of the Common Stock on the principal market for any trading day during the Valuation Period (as defined below), as reported by Bloomberg Finance L.P. or other reputable source. “Valuation Period” means the period of five (5) consecutive trading days immediately following the Clearing Date (as defined below) associated with the applicable Put Notice during which the Purchase Price of the Common Stock is valued, provided, however, that the Valuation Period shall instead begin on the Clearing Date if the respective Put Shares are received as DWAC Shares in the applicable Investor’s brokerage account prior to 11:00 a.m. EST on the respective Clearing Date. “Clearing Date” means the date on which an Investor receives the Put Shares as DWAC Shares in its brokerage account.

	Common Stock Warrants
December 31, 2020		2,640,625	*
Less: Exercised		-
Less: Cancelled		-
Add: Issued
March 31, 2021		2,640,625

Concurrently with the execution of the Purchase Agreement, the Company, SBI and Oasis entered into a Registration Rights Agreement, dated as of October 24, 2019 (the “Registration Rights Agreement”). Pursuant to the Registration Rights Agreement, the Company shall by December 8, 2019, file with the SEC an initial registration statement on Form S-1 covering the maximum number of Registrable Securities (as defined below) as shall be permitted to be included in accordance with applicable SEC rules, regulations and interpretations so as to permit the resale of such Registrable Securities by the Investors, including but not limited to under Rule 415 under the Securities Act at then prevailing market prices (and not fixed prices), as mutually determined by both the Company and the Investors in consultation with their respective legal counsel. “Registrable Securities” means all of the Put Shares which have been, or which may, from time to time be issued, including without limitation all of the shares of Common Stock which have been issued or will be issued to an Investor under the Purchase Agreement (without regard to any limitation or restriction on purchases), and any and all shares of capital stock issued or issuable with respect to Put Shares (as such terms are defined in the Purchase Agreement) issued or issuable to an Investor, and shares of Common Stock issued to an Investor with respect to the Put Shares and the Purchase Agreement as a result of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise, without regard to any limitation on purchases under the Purchase Agreement.

Warrants (Note 3)		1,111,842
Exercise Price	$	0.380
Expiration Date		March 2, 2025

AsThe ~~compensation~~fair ~~for~~value of the ~~commitments~~warrants ~~made~~at ~~under~~issuance ~~the~~was ~~Purchase Agreement~~$577,868, ~~the~~with ~~Company~~an ~~paid~~expiration toof ~~the~~March ~~Investors~~2, a2025 ~~commitment~~and ~~fee~~exercise ~~equal~~price ~~to four percent (4%)~~ of ~~the Maximum Commitment Amount (the “Commitment Fee”)~~$0.380. ~~The~~During ~~Commitment Fee was paid by~~ the ~~Company~~year byended ~~issuing~~December ~~to the Investors 28~~31,~~572~~ ~~shares of the Company’s Series B Preferred Stock, authorized on February 25,~~ 2020 ~~and issued as on February 25~~, ~~2020 with~~ the ~~amount~~exercise ofprice ~~$400,000~~was ~~recorded~~reset to ~~deferred financing costs~~$0.16. The fair value ~~was~~of ~~determined based on~~ the ~~issuance~~warrants ~~price mutually agreed upon between the parties~~ as at ~~the~~March ~~date~~31, of2021 ~~issuance~~was $473,759.

F-13

Note ~~10-~~7 ~~Lease~~– Related Party Transactions

During the three months ended March 31, 2021, an amount of $11,374 in payments were made to the CEO. Included the due to related party balance sheet account was a balance of $69,903 owing to the current CEO of the Company as of March 31, 2021, which were unsecured, bore no interest and were due on demand.

Note 8- Stockholders’ Deficiency

Class A and Class B Common Stock Reverse Stock Split

On October 16, 2020, the board of directors (the “Board”) of the Company and a stockholder holding a majority of the voting power of the Company’s voting stock (the “Majority Stockholder”) took action by joint written consent in lieu of a meeting to: (i) ratify the approval of an amendment to the Company’s certificate of incorporation, which amendment was filed with the Delaware Secretary of State on December 19, 2019 and was declared effective on January 20, 2020 (the “December 2019 Amendment”), which (i) changed the Company’s name from “Capital Park Holdings Corp.” to “Bridgeway National Corp.” and (ii) increased our authorized capital stock from 30,000,000 shares to 250,000,000 shares, of which 168,750,000 shares were designated as Class A Common Stock (the “Class A Common Stock”), 18,750,000 shares were designated as Class B Common Stock (the “Class B Common Stock”) and 62,500,000 shares were designated as preferred stock, of which 62,374,819 shares were previously designated as Series A Preferred Stock (the “Series A Preferred Stock”) and 125,181 shares were previously designated as Series B Preferred Stock (the “Series B Preferred Stock”); (ii) approve a further amendment to the Company’s certificate of incorporation (the “Recapitalization Amendment”) to increase the Common Stock from 187,500,000 shares to 400,000,000 shares, of which 360,000,000 shares will be designated as the Class A Common Stock and 40,000,000 shares will be designated as the Class B Common Stock and (iii) approve an additional amendment to the certificate of incorporation to effect a reverse stock split of our outstanding shares of our Class A Common Stock and Class B Common Stock at the at the ratio of one-for-4 (the “Reverse Stock Split Amendment,” and together with the December 2019 Amendment and the Recapitalization Amendment, collectively, the “Amendments”).

The December 2019 Amendment will not be deemed ratified, and the Recapitalization Amendment and Reverse Stock Split Amendment will not be made effective until at least twenty (20) calendar days after the mailing of the Information Statement accompanying this Notice. In addition, the Reverse Stock Split Amendment will not be made effective until the Recapitalization Amendment is made effective and we receive FINRA approval for the Reverse Stock Split from the Financial Industry Regulatory Authority (“FINRA”). We received written notification that FINRA had approved the Reverse Stock Split on February 17, 2021.

Preferred Stock

During the three-month period ended March 31,2021, the Company declared $9,986 in dividends on the Series B Preferred Stock, of which $9,986 was accrued as a dividend payable.

F-14

Note 9- Lease

The Company entered into an operating lease agreement with a scheduled commencement date on January 15, 2020 for a sixty-seven-month term, with an option to renew for a five-year term.

The Company adopted ASC 842 – Leases using the modified retrospective cumulative catch-up approach beginning on January 1, 2019. Under this approach, the Company did not restate its comparative amounts and recognized a right-of-use asset equal to the present value of the future lease payments. The Company elected to apply the practical expedient to only transition contracts which were previously identified as leases and elected to not recognize right-of-use assets and lease obligations for leases of low value assets.

When measuring the right of use liabilities, the Company discounted lease payments using its incremental borrowing rate at January 15, 2020. The weighted-average-rate applied is 12%.

	$
Operating lease right-of-use asset – initial recognition		879,635
Operating lease right-of-use asset at December 31, 2020		722,088
Amortization		(~~118~~39,~~160~~386	)
Balance at September 30, 2020		761,475
Balance at March 31, 2021		682,702
Right of use liabilities – operating leases – initial recognition		879,635
Right of use liabilities – operating leases at December 31, 2020		773,004
Principal repayment		(7829,~~774~~998	)
Balance at September 30, 2020		800,861
Balance at March 31, 2021		743,006
Current portion of right of use liabilities – operating leases		~~120~~130,~~590~~644
Noncurrent portion of right of use liabilities – operating leases		~~680~~612,~~271~~362

The operating lease expense was $~~193~~52,~~860~~779 for the ~~nine~~three months ended ~~September~~March 3031, ~~2020~~2021 and included in the general and administrative expenses.

The following table represents the contractual undiscounted cash flows for right of use liabilities – operating leases due within ~~twelve~~ twelve months of ~~September~~March 3031,2021

	$
2020		209,827
2021		158,336
2021		215,072
2022		216,392
2022		220,449
2023		221,802
2023		225,961
2024		227,347
2024		192,771
2025		135,934
thereafter		-
Total minimum lease payments		959,811
Total minimum lease payments		1,064,080
Less: effect of discounting		(216,805	)
Less: effect of discounting		(263,219	)
Present value of future minimum lease payments		743,006
Present value of future minimum lease payments		800,861
Less: current portion of right of use liabilities – operating leases		130,644
Less: current portion of right of use liabilities – operating leases		120,590
Noncurrent portion of right of use liabilities – operating leases		612,362
Noncurrent portion of right of use liabilities – operating leases		680,271

FNote 10-14 Subsequent Events

~~Note~~On 11March 31, 2021, Bridgeway was approved for a SBA Loan-1 ~~Acquisition~~in the amount of $723,743. SBA Loan-1 shall be eligible for forgiveness if during the 8-to-24-week covered period following disbursement: (i) employee and ~~discontinued~~compensation ~~operations~~levels are maintained; (ii) the loan proceeds are spent on payroll costs and other eligible expenses and (iii) at least 60% of the proceeds are spent on payroll costs. For any portion of the SBA Loan-1 that is not forgiven, it will bear interest at a 1% fixed APR for the life of the loan with payments deferred for ten (10) months. Subsequent to the approval, cash was received as of April 2021.

The Company entered into an agreement (the “Transaction Agreement”) on May 3, 2019 with C-PAK, P&G, and Capital Park Holdings Corp., solely in its capacity as guarantor, for an acquisition of certain assets pertaining to the “Joy” and “Cream Suds” trademarks for $30,000,000.

As at October 1, 2019, the Transaction Agreement was terminated between the parties. The terms of the termination are undergoing further negotiations. Results of operations, financial position and cash flows for these businesses are separately reported as discontinued operations.

Financial information for discontinued operations, for the three and nine months ended September 30, 2020:

	Three months ended September 30, 2020		Nine months ended September 30, 2020
Expenses		-		-
Other income (expenses)
Other income		-		-
Interest expense		-		-
Loss before income tax provision		-		-
Benefit (provision) for income taxes		-		-
Loss from discontinued operations, net of taxes		-		-

There were no assets or liabilities of discontinued operations held as at September 30, 2020 and December 31, 2019.

Note 12- Subsequent events

The Company’s management has evaluated subsequent events up to November 16, 2020, the date the unaudited consolidated financial statements were issued, pursuant to the requirements of ASC 855 and has determined the following material subsequent events:

On October 3, 2020, the Company issued a convertible debenture, to a non-related party, in the amount of $155,000. Pursuant to the agreement, the note was issued with an original issue discount of $5,000 and as such the purchase price was $150,000. Under the terms of the debenture, the amount is unsecured, bears interest at 6% per annum (18% default interest rate), and is due on June 30, 2021. The debenture is convertible into common shares of the Company at a conversion price $0.04.

Effective October 15, 2020, Bridgeway entered into two purchase agreements (the “Purchase Agreements”) pursuant to which we agreed to acquire 100% of the outstanding capital stock of Merchandize Liquidators, Inc., a Miami-Florida based direct wholesale and retail liquidator of surplus merchandise (“MLI”). The first Purchase Agreement with CW Merchandize Liquidators, LLC (“CW Merchandize”), the minority shareholder of MLI (the “CW Merchandize Purchase Agreement”), provides for the acquisition of CW Merchandize’s shares in MLI in exchange for payment of cash consideration of $6.999 million. The second Purchase Agreement with Edgar Martinez, the majority shareholder of MLI (the “Martinez Purchase Agreement”), provides for the acquisition of his shares in MLI in exchange for the issuance of 252,644,000 shares of Bridgeway Class A Common Stock. As of date of filing, the date of closing has yet to be scheduled.

F-15

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements. The Securities and Exchange Commission encourages companies to disclose forward-looking information so that investors can better understand a company’s future prospects and make informed investment decisions. This report and other written and oral statements that we make from time to time contain such forward-looking statements that set out anticipated results based on management’s plans and assumptions regarding future events or performance. We have tried, wherever possible, to identify such statements by using words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “will” and similar expressions in connection with any discussion of future operating or financial performance. In particular, these include statements relating to future actions, future performance or results of current and anticipated sales efforts, expenses, the outcome of contingencies, such as legal proceedings, and financial results.

We caution that the factors described herein, and other factors could cause our actual results of operations and financial condition to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The Company

Results of Operations

Three months ended ~~September~~March 3031, ~~2020~~2021, as compared to three months ended ~~September~~March 3031, ~~2019~~2020

The following comparative analysis on results of operations was based primarily on the comparative consolidated financial statements, ~~footnotes~~ footnotes and related information for the periods identified below and should be read in conjunction with the consolidated financial ~~statements~~ statements and the notes to those statements that are included elsewhere in this report. The results discussed below are for the three months ended March ~~September 30~~31, ~~2020~~2021 and ~~2019~~2020. For comparative purposes, we are comparing the three months ended ~~September~~March 3031, ~~2020~~ 2021, to the three months ended March ~~September 30~~31, ~~2019~~2020. The following discussion should be read in conjunction with the Company’s consolidated financial statements and the related notes included in this quarterly report.

Revenue

Total revenue was $0 for the three-month periods ended ~~September~~March 3031, ~~2020~~2021 and ~~September~~March 3031, ~~2019~~2020, respectively.

-3-

Cost of Revenue

We had no cost of revenues for the period ended ~~September~~March 3031, ~~2020~~2021 or the period ended ~~September~~March 3031, ~~2019~~2020 as we had no revenues.

Operating Expenses

Total operating expenses were $~~163~~212,~~551~~492 and $14210,~~772~~590 for the three months ended ~~September~~March 3031, ~~2020~~2021 and ~~September~~March 3031, ~~2019~~2020, respectively. ~~The~~ ~~increase is operating~~ Operating expenses ~~can~~were ~~also~~essentially beflat, ~~attributed~~which toreflects the ~~general~~Company’s ~~and~~increased ~~administrative~~ expenses ~~incurred~~associated bywith ~~the~~a ~~Company~~broadening ~~during the~~of ~~period~~its operating strategy.

Other Income (Expenses)

Other ~~income~~expense for the three-month period ended ~~September~~March 3031, ~~2020~~2021 ~~increased~~decreased by $~~896~~1,~~106~~758,843 compared to the three-month period ended ~~September~~ 30March 31, ~~2019~~2020, as a result of ~~the~~a ~~increase~~decrease in the ~~interest expense,~~ loss on derivative liabilities~~, and loss of the change in fair value of derivative liabilities~~.

Net Profit (Loss)

The net profit (loss) was $(1,059,657) and $452,926 for the three months ended September 30, 2020 and September 30, 2019, respectively. This increase is a result of the increase in operating expenses and other expenses discussed above. In addition, for the three-month period ended September 30, 2019, a balance of $467,698 included in the net profit related to discontinued operations.

Nine months ended September 30, 2020, as compared to nine months ended September 30, 2019

The following comparative analysis on results of operations was based primarily on the comparative consolidated financial statements, footnotes and related information for the periods identified below and should be read in conjunction with the consolidated financial statements and the notes to those statements that are included elsewhere in this report. The results discussed below are for the nine months ended September 30, 2020 and 2019. For comparative purposes, we are comparing the nine months ended September 30, 2020, to the nine months ended September 30, 2019. The following discussion should be read in conjunction with the Company’s consolidated financial statements and the related notes included in this quarterly report.

Revenue

Total revenue was $0 for the nine-month periods ended September 30, 2020 and September 30, 2019, respectively.

Cost of Revenue

We had no cost of revenues for the period ended September 30, 2020 or the period ended September 30, 2019 as we had no revenues.

Operating Expenses

Total operating expenses were $697,872 and $255,393 for continuing operations for the nine months ended September 30, 2020 and September 30, 2019, respectively. The increase is operating expenses can also be attributed to the general and administrative expenses incurred by the company during the period.

Other Income (Expenses)

Other expenses for the nine-month period ended September 30, 2020 increased by $2,170,565 compared to the nine-month period ended September 30, 2019, as a result of the increase in the interest expense and loss on derivatives.

-4-

Net Loss

The net loss was $2254,~~881,043~~683 and $~~254~~2,~~964~~011,624 for the ~~nine~~three months ended ~~September~~March 3031, ~~2020~~2021 and ~~September~~March 3031, ~~2019~~2020, respectively. This ~~increase~~ decrease is a result of ~~the~~a ~~increase~~decrease in ~~operating~~the ~~expenses and~~ other expenses as discussed above. ~~For the nine-month period ended September 30, 2019, a profit balance of $13,035 included in the net loss related to discontinued operations.~~

Liquidity

Liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. As of ~~September 30~~March 31, ~~2020~~2021, our working capital deficit amounted to $23,~~738~~901,050 ~~856~~ an increase of $2118,~~724,789~~041 as compared to $143,~~067~~783,009 as of December 31, ~~2019~~2020. This increase is primarily a result of ~~the~~an ~~Company~~increase ~~entering~~in ~~into~~accrued ~~its operating lease for administrative operations~~expenses.

Net cash used in operating activities ~~for continued operations~~ was ($~~667~~106,~~778~~732) during the ~~nine~~three-month period ended ~~September~~March 3031, ~~2020~~ 2021 compared to ($~~344~~369,~~258~~974) in in the ~~nine~~three-month period ended ~~September~~March 3031, ~~2019~~2020. The ~~increase~~decrease inwas ~~cash used in operating activities is~~ primarily ~~attributable~~due to ana ~~increase~~reduction in ~~the~~operating ~~interest~~expenses ~~expense~~as ~~recognized~~well onas a ~~our~~reduced ~~convertible~~derivative ~~notes~~liability.

Capital Resources

The Company is a holding company and its liquidity needs are primarily for fixed and recurring operational expenses.

As of ~~September~~March 3031, ~~2020~~2021, the Company had $~~147~~90,~~316~~183 of cash and cash equivalents compared to $~~nil~~1,915 as of December 31, ~~2019~~2020.

Our subsidiaries’ principal liquidity requirements arise from cash used in operating activities, debt service, R&D expenditures, development of back-office systems, operating costs and expenses, and income taxes.

We expect to finance our future growth and operations, through public offerings and private placements of debt and equity securities, credit facilities, vendor financing, capital lease financing and other financing arrangements, as well as cash generated from the operations of our subsidiaries. In the future, we may also choose to sell assets or certain investments to generate cash.

At this time, we believe that we will be able to continue to meet our liquidity requirements and fund our fixed obligations and other cash needs for our operations for at least the next twelve months through a combination of distributions from our subsidiaries and from raising of debt or equity, refinancing of certain of our indebtedness or preferred stock, other financing arrangements and/or the sale of assets and certain investments. We anticipate that as we continue to scale our operations, we will reinvest cash and receivables into the growth of our various businesses, and therefore do not anticipate keeping a large amount of cash on hand at the holding company level. The ability of our subsidiaries to make distributions to the Company is and will be in the future subject to numerous factors, including restrictions contained in each subsidiary’s financing agreements, regulatory requirements and the availability of sufficient funds at each subsidiary. Although the Company believes that it will be able to raise equity capital, refinance indebtedness or preferred stock, enter into other financing arrangements or engage in asset sales and sales of certain investments sufficient to fund any cash needs that we are not able to satisfy with the funds expected to be provided by our subsidiaries, there can be no assurance that it will be able to do so on terms satisfactory to the Company if at all. Such financing options, if pursued, may also ultimately have the effect of negatively impacting our liquidity profile and prospects over the long-term. In addition, the sale of assets or the Company’s investments may also make the Company less attractive to potential investors or future financing partners.

-54-

Current and Future Financings

Subsequent Events

The Company’s management has evaluated subsequent events up to the date the unaudited consolidated financial statements were issued, pursuant to the requirements of ASC 855 and has determined the following material subsequent event:

Inflation

In the opinion of management, inflation has not and will not have a material effect on our operations in the immediate future. Management will continue to monitor inflation and evaluate the possible future effects of inflation on our business and operations.

Off-Balance Sheet Arrangements

Under SEC regulations, we are required to disclose our off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, such as changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors. As of the date the unaudited consolidated financial statements were issued, we have no off-balance sheet arrangements.

-65-

CRITICAL ACCOUNTING POLICIES

Our significant accounting policies are disclosed in Note 2 of our Unaudited Consolidated Financial Statements included elsewhere in this Quarterly Report.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this Item 3.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”) that are designed to ensure that information required to be disclosed by us in reports that we file under the Exchange Act is recorded, processed, summarized and reported as specified in the SEC’s rules and forms and that such information required to be disclosed by us in reports that we file under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer, or CEO, and our Chief Financial Officer, CFO, to allow timely decisions regarding required disclosure.

As previously reported in our Annual Report on Form 10-K for the fiscal year ended December 31, ~~2019~~2020, we identified material weaknesses in internal controls over financial reporting. We have continued to address and mitigate these material weaknesses through the ~~implementation~~ implementation and testing of controls, including taking the following actions:

	●	Ensure that controls that are properly designed are adequately performed to appropriately address risk related to critical functionality.

	●	Further rationalize documented controls to ensure adequacy of risk mediation.

	●	Embed a specific and precise journal entry review and approval process at the subsidiary locations, utilizing systematic workflow approval wherever feasible.

	●	Finalize and implement a company-wide formal delegation of authority policy with defined authorization levels and integrate these approval limits with our enterprise resource planning system or other invoice approval software as appropriate.

	●	Continue the process of the identification of qualified accounting personnel, including the hiring of a corporate controller and other accounting personnel over the next several months.

While management believes that it has identified the initiatives that need to be undertaken, the controls as described above are in the process of being implemented and have not had sufficient time for management to conclude that they are operating effectively. Therefore, the material weaknesses reported will continue to exist until the aforementioned controls have had sufficient time for management to conclude that they are operating effectively.

Notwithstanding the assessment that our internal control over financial reporting is not effective and that there were material weaknesses as identified in this report, based on our reliance on third parties to provide us with accounting consulting services, ongoing testing and procedures performed, management and our principal executive officers, believe the financial statements included in this Quarterly Report on Form 10-Q fairly represent in all material respects our financial position, results of operations and cash flows at and for the periods covered thereby in all material respects.

-6-

Changes in Internal Control

Other than as disclosed above, there have not been any changes identified in connection with our internal control over financial reporting, as such term is defined in Rules 13(a)-15(f) and 15d-15(f) under the Exchange Act, during the period of this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

-7-

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are not presently a party to any material litigation, nor to the knowledge of management is any litigation threatened against us that may materially affect us.

ITEM 1A. RISK FACTORS

Not applicable to smaller reporting companies.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

-7-

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibit No.		Description

3.1		Certificate of Designation of Series B Preferred Stock filed with the Nevada Secretary of State on January 9, 2019 (incorporated ‎by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on January 15, 2019).‎

10.1		Note Conversion Agreement, dated January 9, 2019, among LifeLogger Technologies Corp., Capital Park Opportunities Fund ‎LP, SBI Investments LLC, 2014-1 and Old Main Capital, LLC (incorporated by reference to Exhibit 10.1 to the Company’s ‎Current Report on Form 8-K filed with the SEC on January 15, 2019).‎‎

10.2		Voting and First Refusal Agreement, dated January 9, 2019, among LifeLogger Technologies Corp., Capital Park Opportunities ‎Fund LP, SBI Investments LLC, 2014-1 and Old Main Capital, LLC (incorporated by reference to Exhibit 10.2 to the ‎Company’s Current Report on Form 8-K filed with the SEC on January 15, 2019)‎.

31.1*		Section 302 Certification of Principal Executive Officer.

31.2*		Section 302 Certification of Principal Financial Officer.

32.1*		Section 906 Certification of Principal Executive Officer.

32.2*		Section 906 Certification of Principal Financial Officer.

101.INS*		XBRL Instance Document

101.SCH*		XBRL Taxonomy Extension Schema Document

101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*		XBRL Taxonomy Extension Label Linkbase Document

101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document

* Filed herewith.

-8-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	BRIDGEWAY NATIONAL CORP.
Dated: November 16, 2020	By:	/s/ Eric C. Blue
Dated: June 14, 2021	By:	/s/ Eric C. Blue
		Eric C. Blue
		Chairman of the Board, Chief Executive Officer and Chief Investment Officer
		(Principal Executive Officer)

-9-

Filing Compare · BRIDGEWAY NATIONAL CORP.